Clinical Trial Update: A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes [Phase 2]

View source ↗

Summary

This document announces the completion of a Phase 2 clinical trial evaluating various doses of NNC0487-0111 to lower blood sugar in adults with Type 2 diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Type 2 Diabetes (T2D) | Phase 2 | Status: COMPLETED